Overexpression of VEGF165b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Circulation Research

• Publication date

  2011-07-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.111.242057PMID 21636803
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis

  2010cited by this paper
• Balance of pro‐ versus anti‐angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth

  2010cited by this paper
• Abnormalities in the Regulators of Angiogenesis in Patients with Scleroderma

  2009cited by this paper
• The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis

  2009cited by this paper
• Therapeutic potential of manipulating VEGF splice isoforms in oncology.

  2009cited by this paper
• The anti-angiogenic isoforms of VEGF in health and disease.

  2009cited by this paper
• VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

  2008cited by this paper
• The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice

  2008cited by this paper
• p73 isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis

  2008influential reference
• Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

  2008cited by this paper
• Levels of vascular endothelial growth factor-A165b (VEGF-A165b) are elevated in experimental glaucoma

  2008cited by this paper
• Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection.

  2007influential reference
• Vascular complications of scleroderma.

  2007cited by this paper
• Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma

  2007cited by this paper
• Systemic sclerosis: a prototypic multisystem fibrotic disorder.

  2007cited by this paper
• The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis.

  2006cited by this paper
• Domain 1 of the urokinase-type plasminogen activator receptor is required for its morphologic and functional, beta2 integrin-mediated connection with actin cytoskeleton in human microvascular endothelial cells: failure of association in systemic sclerosis endothelial cells.

  2006cited by this paper
• VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice.

  2006cited by this paper
• VEGF receptor signalling ? in control of vascular function

  2006cited by this paper
• Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor

  2005cited by this paper
• Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)

  2005cited by this paper
• VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant

  2004cited by this paper
• Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis

  2004cited by this paper
• Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis.

  2004cited by this paper
• Elevated vascular endothelial growth factor in systemic sclerosis.

  2003cited by this paper
• VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.

  2002cited by this paper
• Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin.

  2002cited by this paper
• Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

  2002cited by this paper
• Transforming growth factor-&bgr; and connective tissue growth factor: key cytokines in scleroderma pathogenesis

  2001cited by this paper
• Criteria for the classification of early systemic sclerosis.

  2001cited by this paper
• Culturing endothelial cells of microvascular origin.

  2000cited by this paper
• Mechanisms of angiogenesis and arteriogenesis

  2000cited by this paper
• Vascular endothelial growth factor (VEGF) and its receptors

  1999cited by this paper
• The biology of vascular endothelial growth factor.

  1997cited by this paper
• SYSTEMIC SCLEROSIS : A Vascular Perspective

  1996cited by this paper
• Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants

  1996cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.

  1995cited by this paper
• The isolation and culture of microvascular endothelium.

  1993cited by this paper
• The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

  1991cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• Systemic sclerosis.

  1968cited by this paper

• Drug development in systemic sclerosis: novel therapeutics to watch.

  2026cites this paper
• Tumor-promoting effect and tumor immunity of SRSFs

  2025cites this paper
• Systemic sclerosis, main culprits and involved signaling pathways

  2025cites this paper
• Increased serum anti-angiogenic factor levels in insulin-resistant obese children and adolescents with or without liver steatosis (NAFL)

  2025cites this paper
• Role of Growth Factors in the Pathogenesis of Systemic-Sclerosis-Associated Fibrosis

  2025cites this paper
• Renal Tubular Epithelial Cell–Derived hsa_circ_0008925 From Urine Is Related to Chronic Renal Fibrosis

  2025cites this paper
• Macrophage-secreted U2AF1 Orchestrates Coronary Artery Angiogenesis to Facilitate Myocardial Infarction Repair through the Regulation of Yap1 Variable Splicing

  2025cites this paper
• Alternative Splicing-Mediated Resistance to Antibody-Based Therapies: Mechanisms and Emerging Therapeutic Strategies

  2025cites this paper
• Examining the relationship between vascular biomarkers and both microangiopathy and cutaneous fibrosis in systemic sclerosis

  2025influential citation
• SRSF6 modulates histone-chaperone HIRA splicing to orchestrate AR and E2F activity in prostate cancer

  2024cites this paper
• Elucidating the phosphoregulatory network of predominant phosphosite in AXL kinase: an integrative bioinformatic approach

  2024cites this paper
• What have we learned on pre, very early, and early systemic sclerosis microcirculatory pathophysiology? A scoping review.

  2024cites this paper
• Vascular endothelial growth factor as a potential biomarker in systemic sclerosis: a systematic review and meta-analysis

  2024cites this paper
• Molecular characteristics and clinical implications of serine/arginine-rich splicing factors in human cancer

  2023cites this paper
• Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review

  2023cites this paper
• Extracellular Matrix-Derived Damage-Associated Molecular Patterns: Implications in Systemic Sclerosis and Fibrosis.

  2023cites this paper
• Further insight into systemic sclerosis from the vasculopathy perspective.

  2023cites this paper
• A Molecular Troika of Angiogenesis, Coagulopathy and Endothelial Dysfunction in the Pathology of Avascular Necrosis of Femoral Head: A Comprehensive Review

  2023cites this paper
• Efficacy analysis of minimally invasive surgery for Raynaud’s syndrome

  2023cites this paper
• A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis

  2022cites this paper
• The VEGF/VEGFR Axis Revisited: Implications for Cancer Therapy

  2022cites this paper
• Altered pathways of keratinization, extracellular matrix generation, angiogenesis, and stromal stem cells proliferation in patients with systemic sclerosis

  2022cites this paper
• Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer

  2022cites this paper
• Insights into established and emerging roles of SR protein family in plants and animals

  2022cites this paper
• SR Splicing Factors Promote Cancer via Multiple Regulatory Mechanisms

  2022cites this paper
• Bevacizumab may differentially improve prognosis of advanced ovarian cancer patients with low expression of VEGF-A165b, an anti-angiogenic VEGF-A splice variant.

  2022cites this paper
• Cellular and molecular diversity in rheumatic autoimmune diseases.

  2022cites this paper
• Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells.

  2022cites this paper
• Part I: Epidemiology, Pathophysiology, and Clinical Considerations of Primary and Secondary Raynaud's Phenomenon.

  2022cites this paper
• Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions

  2022cites this paper
• How VEGF-A and its splice variants affect breast cancer development – clinical implications

  2022cites this paper
• Neutrophil Extracellular Traps, Angiogenesis and Cancer

  2022cites this paper
• Is Netrin-1 Associated with the Development of Fibrosis in Systemic Sclerosis?

  2022cites this paper
• Involvement of Multiple Variants of Soluble CD146 in Systemic Sclerosis: Identification of a Novel Profibrotic Factor

  2022cites this paper
• New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy

  2021cites this paper
• Retinopathy of prematurity shows alterations in Vegfa164 isoform expression

  2021cites this paper
• Tyrosine Kinases in the Pathogenesis of Tissue Fibrosis in Systemic Sclerosis and Potential Therapeutic Role of their Inhibition.

  2021cites this paper
• Endostatin and Vascular Endothelial Growth Factor-A165b May Contribute to Classification of Pulmonary Hypertension

  2021cites this paper
• Endothelial‐to‐mesenchymal transition in systemic sclerosis

  2021cites this paper
• Targeting Splicing Factor SRSF6 for Cancer Therapy

  2021cites this paper
• Current Concepts on the Pathogenesis of Systemic Sclerosis

  2021cites this paper
• Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential

  2021cites this paper
• Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease

  2021cites this paper
• Splicing factor SRSF6 mediates pleural fibrosis

  2021cites this paper
• Interplay between IL-17 family members and angiogenic cytokines in subjects with systemic sclerosis.

  2021cites this paper
• Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer

  2020cites this paper
• Debunking the Myth of the Endogenous Antiangiogenic Vegfaxxxb Transcripts.

  2020cites this paper
• VEGF-A splice variants bind VEGFRs with differential affinities

  2020cites this paper
• The Production of Pro-angiogenic VEGF-A Isoforms by Hypoxic Human NK Cells Is Independent of Their TGF-β-Mediated Conversion to an ILC1-Like Phenotype

  2020cites this paper
• Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease.

  2019cites this paper
• The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis.

  2019cites this paper
• Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population

  2019cites this paper
• [Updates in systemic sclerosis pathogenesis: Toward new therapeutic opportunities].

  2019cites this paper
• Correction: Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population

  2019cites this paper
• Contribution of the VEGF system to the follicular persistence associated with bovine cystic ovaries.

  2019cites this paper
• Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.

  2019cites this paper
• Pathophysiology of systemic sclerosis: current understanding and new insights

  2019cites this paper
• Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis

  2018cites this paper
• Epigenetics and pathogenesis of systemic sclerosis; the ins and outs.

  2018cites this paper
• Adipose‐derived stem cells decrease pain in a rat model of oxaliplatin‐induced neuropathy: Role of VEGF‐A modulation

  2018cites this paper
• SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform.

  2018cites this paper
• Levels of EGF and VEGF in patients with primary and secondary Sjögren's syndrome.

  2018cites this paper
• Diabetes‐induced microvascular complications at the level of the spinal cord: a contributing factor in diabetic neuropathic pain

  2018cites this paper
• Targeting Splicing in Prostate Cancer

  2018cites this paper
• Whole-Body Distribution and Clinical Association of Telangiectases in Systemic Sclerosis

  2018cites this paper
• The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis

  2018cites this paper
• The role of skin and muscle biopsy in the diagnosis of main connective tissue diseases.

  2018cites this paper
• Association between the ratio of anti-angiogenic isoform of VEGF-A to total VEGF-A and adverse clinical outcomes in patients after acute myocardial infarction

  2018cites this paper
• VEGF165b mutant with a prolonged half-life and enhanced anti-tumor potency in a mouse model.

  2018cites this paper
• Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin

  2018cites this paper
• Vascular Mechanisms of Systemic Sclerosis

  2018cites this paper
• Physiological Role of Vascular Endothelial Growth Factors as Homeostatic Regulators.

  2018cites this paper
• (2018). The Role of Vascular Endothelial Growth Factor in Systemic Sclerosis. Current Rheumatology Reviews

  2018influential citation
• Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis

  2017cites this paper
• Systems Pharmacology of VEGF165b in Peripheral Artery Disease

  2017cites this paper
• [Tolerance of bevacizumab therapy in systemic sclerosis-associated pulmonary arterial hypertension: A case report].

  2017cites this paper
• Novel approaches to identify biomechanisms in systemic sclerosis

  2017cites this paper
• Biology and therapeutic implications of VEGF‐A splice isoforms and single‐nucleotide polymorphisms in colorectal cancer

  2017cites this paper
• Endogenous ligands of TLR 4 promote unresolving tissue fibrosis : implications for systemic sclerosis and its targeted therapy Running title : DAMP-TLR 4 activation drives persistent fibrosis in SSc

  2017cites this paper
• Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy.

  2017cites this paper
• Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview

  2017cites this paper
• Group V Secreted Phospholipase A2 Induces the Release of Proangiogenic and Antiangiogenic Factors by Human Neutrophils

  2017cites this paper
• Vascular Endothelial Growth Factor in Idiopathic Pulmonary Fibrosis. An Imbalancing Act.

  2017cites this paper
• Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis

  2017cites this paper
• Tie2 as a novel key factor of microangiopathy in systemic sclerosis

  2017cites this paper
• Pharmacology of Modulators of Alternative Splicing

  2017cites this paper
• An update on biomarker discovery and use in systemic sclerosis

  2017cites this paper
• The Measurement of the Endothelial Glycocalyx as a New Biomarker of Endothelial Derangement in Systemic Sclerosis: A Challenge for the Future

  2017cites this paper
• Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients

  2017cites this paper
• Unmet Needs in Systemic Sclerosis Understanding and Treatment: the Knowledge Gaps from a Scientist’s, Clinician’s, and Patient’s Perspective

  2017cites this paper
• The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.

  2017cites this paper
• Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis

  2017cites this paper
• Deregulated angiogenesis in chronic lung diseases: a possible role for lung mesenchymal progenitor cells (2017 Grover Conference Series)

  2017cites this paper
• Dynamics and implications of circulating anti-angiogenic VEGF-A165b isoform in patients with ST-elevation myocardial infarction

  2017cites this paper
• Antiangiogenic VEGF 165 b Expression in Human Breast MCF-7 and MCF-10 A Cells Exposed to Reverse Transcriptase and Protease Inhibitors

  2017cites this paper
• Tolérance du bévacizumab au cours de l’hypertension artérielle pulmonaire associée à la sclérodermie systémique : à propos d’une observation

  2017cites this paper
• Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells

  2017cites this paper
• Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement

  2016cites this paper
• Histone Deacetylase 5 Is Overexpressed in Scleroderma Endothelial Cells and Impairs Angiogenesis via Repression of Proangiogenic Factors

  2016cites this paper
• The Scenario : Damage and Remodelling of the Microvasculature in Systemic Sclerosis

  2016cites this paper